Development of a Novel Inhibitory Chimeric Anti-HER2 Monoclonal Antibody

Amiri, Mohammad Mehdi; Bahadori, Tannaz; Soltantoyeh, Tahereh; Hosseini-Ghatar, Reza; Golsaz-Shirazi, Forough; Jeddi-Tehrani, Mahmood; Shokri, Fazel

doi:https://dx.doi.org/10.22034/IJI.2019.39404

(ندگان)پدیدآور

Amiri, Mohammad MehdiBahadori, TannazSoltantoyeh, TaherehHosseini-Ghatar, RezaGolsaz-Shirazi, ForoughJeddi-Tehrani, MahmoodShokri, Fazel

نوع مدرک

Text
Original Article

زبان مدرک

English

نمایش کامل رکورد

شماره نشریه

تاریخ نشر

2019-03-01
1397-12-10

ناشر

Shiraz Institute for Cancer Research

سازمان پدید آورنده

Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran
Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran
Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran
Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran
Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran
Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran
Department of Immunology, School of Public Health, Tehran University of Medical Sciences,

شاپا

1735-1383
1735-367X

URI

https://dx.doi.org/10.22034/IJI.2019.39404
https://iji.sums.ac.ir/article_44697.html
https://iranjournals.nlai.ir/handle/123456789/329221